Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Interleukin-1 Β Gene Polymorphisms in Iranian Patients With Uterine Fibroid, a Case-Control Study Publisher



Mortezaee FT1 ; Chaleshtori MH1 ; Kheiri S2 ; Farrokhi E1 ; Shariati L3 ; Tabatabaiefar MA1, 4 ; Miraj S5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cellular and Molecular Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  2. 2. Clinical Biochemistry Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran
  3. 3. Department of Molecular Medicine, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Medical Genetics, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  5. 5. Deparmment of Obstetrics of Gynecology, Hajar Hospital, Shahrekord University of Medical Sciences, Shahrekord, Iran

Source: Biosciences Biotechnology Research Asia Published:2015


Abstract

Uterine leiomyoma (UL) or fibroid is the most common estrogen- dependent tumor of the reproductive system. Almost a quarter of women at reproductive age are affected with this benign tumor. The purpose of the present study was to investigate the possible association of IL-1β-511and IL-1β 3954 polymorphisms with UL in the women of Charmahal & Bakhtiari province of Iran. Totally, 276 patients with UL and 157 healthy control women were studied. The genetic polymorphisms for IL-1β-511and IL-1β 3954 were analyzed by PCR-RFLP method. The results were analyzed with SPSS software using χ2 test. The TC genotypes of the IL-1β -511C/T polymorphism showed a decreased risk of UL (OR = 0.232, P = 0.01, 95 % CI = 0.11 - 0.48). A significant difference was found for the C allele frequencies of the IL-1 β -511 C>T polymorphism between the two groups (OR = 0.232, P = 0.01, 95% CI = 0.11 - 0.48). However, no significant difference was found for the IL-1 a -3954 polymorphism between the two groups. Our findings indicated that IL-1 a -511C>T promoter polymorphism affects the risk of UL in the women of our study and this polymorphism might be involved in the pathogens of this disease.